Bio Essence Corp has announced plans to amend its Articles of Incorporation to provide super voting rights for future preferred shareholders. This change, which allows one share of preferred stock to equate to ten thousand votes, aims to enhance control for preferred shareholders without diluting the interests of common stockholders. This strategic move reflects a broader trend in the pharmaceutical preparations industry, where companies are increasingly exploring governance structures that align with evolving business models.
The amendment was approved unanimously by the Board of Directors on October 19, 2026, and received the consent of shareholders holding a majority of the outstanding shares of common stock. The company will file a Certificate of Amendment with the California Secretary of State following a mandatory 20-day waiting period after the Definitive Information Statement is mailed to shareholders.
Background
Bio Essence Corp, incorporated in California, operates in the pharmaceutical preparations industry (SIC 2834). The company is listed on the OTC exchange under the ticker symbol BIOE. Recent filings indicate a shift in its business model, moving from traditional health products to a technology-enabled healthcare platform.
What the Filing Says
The filing states, "The Company will, when permissible following the expiration of the twenty-day (20) period mandated by Rule 14c and the provisions of the California Corporations Code, file a Certificate of Amendment of Articles of Incorporation to amend our Articles implementing the new voting rights for preferred shareholders." The amendment is designed to ensure that future holders of preferred stock have enhanced voting power compared to common stockholders.
Impact
This change may significantly affect the governance structure of Bio Essence Corp, allowing for more concentrated control among preferred shareholders. As there are currently no shares of preferred stock issued and outstanding, this amendment sets the stage for future capital raises or strategic partnerships that could involve preferred shares.
What's Next
The company plans to mail the Definitive Information Statement to shareholders on or about November 20, 2026, and will proceed with the filing of the amendment after the 20-day waiting period.